07:00 , Jun 6, 2016 |  BC Week In Review  |  Financial News

argenx completes private placement

argenx N.V. (Euronext:ARGX), Breda, the Netherlands   Business: Antibodies, Cancer, Autoimmune   Date completed: 2016-06-03   Type: Private placement   Raised: EUR30 million ($33.4 million)   Shares: 2.7 million   Price: EUR11.10   Shares after...
00:18 , Jun 4, 2016 |  BC Extra  |  Financial News

argenx raises EUR 30 million

argenx N.V. (Euronext:ARGX) raised EUR 30 million ($33.4 million) through the sale of 2.7 million shares at EUR 11.10 in a private placement, mainly with U.S. investors. The price was a 3% discount to argenx's...
02:02 , Mar 26, 2015 |  BC Extra  |  Financial News

Cellectis raises $228.3M, lists in U.S.

Immunotherapy company Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS) lost $2.20 to $39.30 in its first day of trading on NASDAQ on Wednesday after raising $228.3 million through the sale of 5.5 million American Depositary Shares (ADSs) at...
08:00 , Jan 9, 2015 |  BC Extra  |  Financial News

CAR play Cellectis plans listing in U.S.

Cellectis S.A. (Euronext:ALCLS) on Thursday said it plans to list on a U.S. exchange, but has not yet decided on the date, size or terms of the public offering. The immunotherapy play gained EUR 2.90...
08:00 , Jan 9, 2015 |  BC Extra  |  Financial News

CAR play Cellectis plans listing in U.S.

Cellectis S.A. (Euronext:ALCLS) on Thursday said it plans to list on a U.S. exchange, but has not yet decided on the date, size or terms of the public offering. The immunotherapy play gained EUR 2.90...
07:00 , May 26, 2014 |  BioCentury  |  Finance

Europe's Iceberg 2014: Premier League teams

Competing in biotech's Premier League requires deep pockets, long term planning and the risk appetite to pursue novel technologies or targets that don't always pan out. BioCentury's 12th annual European Iceberg survey reveals that for...
07:00 , Apr 7, 2014 |  BC Week In Review  |  Financial News

Cellectis completes placing

Cellectis S.A. (Euronext:ALCLS), Paris, France   Business: Gene/Cell therapy, Genomics   Date completed: 3/31/14   Type: Placing   Raised: €20.5 million ($28.2 million)   Shares: 4 million   Price: €5.13   Shares after offering: 25.1...
07:00 , Mar 31, 2014 |  BC Week In Review  |  Financial News

Cellectis proposes placing

Cellectis S.A. (Euronext:ALCLS), Paris, France   Business: Gene/Cell therapy, Genomics   Date announced: 3/25/14   Type: Placing   To be raised: €20.5 million ($28.3 million)   Shares: 4 million   Price: €5.13   Shares outstanding...
00:30 , Mar 26, 2014 |  BC Extra  |  Financial News

Cellectis to raise EUR 20.5 million in private placement

Cellectis S.A. (Euronext:ALCLS) plans to raise EUR 20.5 million ($28.3 million) through the sale of 4 million shares at EUR 5.13 in a private placement to U.S. institutional investors. The price is a 3% premium...